Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for the 2022 through 2027 period, citing a portfolio shift toward cardiovascular products, operating-m
AbbVie (NYSE:ABBV) executives outlined growth plans across immunology, oncology and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of combination therapies and an approach to business development focused on assets that fit i
Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial hypercholesterolemia, Chief Executive Officer Gilmore O’Neill said during a Wells Fargo discussion.
O’Ne
Medtronic (NYSE:MDT) executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence, robotics and new therapies.
Speaking at the Wells Fargo Healthcare Conference, Chairman and Chief
McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter.
The company said Precision Medicine Group would expand two areas it has id
In the past few months, investment banks have updated year end views on gold (“Au”) to US$4,500-$5,100/oz vs. the current price of ~$4,380. For example, Go
Digital identity verification and fraud prevention provider Socure has achieved a $5.2 billion valuation and buys following a strategic growth investment l
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
What Happened? Shares of payment processing company Shift4 Payments (NYSE:FOUR) jumped 4.6% in the morning session after Wells Fargo upgraded the company to ...
Stephen Weiss picks Dick's Sporting Goods, supported by Wells Fargo's upgrade. Jim Lebenthal's final trade is BlackRock, recommended by Evercore ISI's analyst upgrade. Shannon Saccocia recommends iShares U.S. Industrials ETF and Joseph M. Terranova mentions Charles Schwab breaking up.
Since February 2026, Wells Fargo has been in a holding pattern, posting a small loss of 1.5% while floating around $83.87. The stock also fell short of the S...
What Happened? A number of stocks fell in the afternoon session after the White House pivoted its Iran strategy toward financial sanctions, signaling a de-es...
What Happened? Shares of general merchandise retailer Target (NYSE:TGT) jumped 4.5% in the morning session after second-quarter results beat on sales and the...
Okta shares have rallied about 60% this year as analysts cite rising identity-management spending, AI agent demand, and improved profitability, with Wall Street rating it a Moderate Buy.
